Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Antengene Announces XPOVIO® (selinexor) Approved for Its Third Indication in South Korea, Bringing Fresh Hope to Patients with MM in the Country 2024-10-18 10:35
OmniaBio Announces Opening of New Commercial Manufacturing Facility in Canada, Bringing Life-Saving Cell and Gene Therapies to Patients 2024-10-18 07:00
Exclusive Interview with Lang Guojun, founder of Sanyou Bio: The Key to Breaking the Bottleneck of New Drug Innovation--The Past and Future of the Super-Trillion Molecule Library 2024-10-17 22:00
Chipscreen Biosciences' Innovative Anti-Tumor Drug CS231295 Tablets: Investigational New Drug (IND) Application Accepted 2024-10-17 21:38
Amplo Biotechnology Announces Three Presentations at the European Society of Gene and Cell Therapy 31st Annual Congress 2024-10-17 18:39
Telix Q3 2024 Business Update - Quarterly Revenue Exceeds AU$200M 2024-10-17 15:54
KIND Announces Late-Breaking Abstract Accepted for Presentation on AND017 Clinical Trials to Treat Anemia in Chronic Kidney Disease (CKD) at ASN - Kidney Week 2024 2024-10-17 15:44
Cambrex Opens New Stability Storage Facility in Durham, North Carolina 2024-10-17 15:00
Bio X Cell Announces Board of Director Appointments 2024-10-17 14:00
IND Application for a Phase Ⅲ Clinical Study of KN026 Combined with Albumin-bound Docetaxel as Neoadjuvant Treatment for Breast Cancer was Approved 2024-10-17 10:15
Innovent Announces Phase 2 Clinical Study of Picankibart (IBI112) in Chinese Patients with Ulcerative Colitis Met Primary Endpoint 2024-10-17 08:00
Presagen's AI fertility product Life Whisperer acquired by Astec 2024-10-17 03:11
WuXi Biologics Receives ESG Corporate Platinum Award from The Asset for Fourth Consecutive Year 2024-10-16 20:00
IGCS Late Breaking Abstract and The Lancet: Akeso Published Positive PFS and OS Results from Phase 3 First-Line Study of Cadonilimab in Cervical Cancer 2024-10-16 19:02
TenNor Announces More than 300 Million RMB Financing to Support Development and Commercialization of Late-Stage Assets Including Rifasutenizol for Heliobacter pylori Infections 2024-10-16 18:00
Join the GenScript Biotech Global Forum: Unlocking Innovations in Cell and Gene Therapies 2024-10-16 17:43
Exyte completes acquisition of Kinetics 2024-10-16 17:00
Frost & Sullivan grants the 2024 Global Pluripotent stem cell drug R&D Innovation Award to ZEPHYRM BIOTECHNOLOGIES 2024-10-16 13:35
PharmAust affirms corporate strategy with name change to Neurizon Therapeutics 2024-10-16 04:14
Chiglitazar for the Treatment of MASH Phase II Clinical Study Selected for Oral Presentation at the 2024 American Liver Disease Annual Meeting 2024-10-15 22:08
1 13 14 15 16 17 458